Gemcitabine induced hemolytic uremic syndrome

BACKGROUND: Gemcitabine is frequently used for the treatment of many cancers. Not infrequently it leads to development of hemolytic uremic syndrome, presenting with hemolytic anemia, acute kidney injury and occasionally peripheral edema, livedo reticularis and digital necrosis. CASE REPORT: A 78 yea...

Descripción completa

Detalles Bibliográficos
Autores principales: Sadjadi, Seyed-Ali, Annamaraju, Pavan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615915/
https://www.ncbi.nlm.nih.gov/pubmed/23569497
http://dx.doi.org/10.12659/AJCR.882858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615915/
https://www.ncbi.nlm.nih.gov/pubmed/23569497
http://dx.doi.org/10.12659/AJCR.882858

Ejemplares similares